# Mixed mycotic infection in an immunocompromised host with advanced HIV diagnosed with the assistance of a Karius test

## TL;DR

A woman with advanced HIV had a mixed fungal infection diagnosed using a Karius test, which helped guide faster treatment.

## Contribution

Demonstrates the value of using the Karius test early in diagnosing mixed mycotic infections in immunocompromised patients.

## Key findings

- Karius test detected Pneumocystis jirovecii, Coccidioides posadasii, and Histoplasma capsulatum in an HIV patient.
- Standard tests later confirmed the mixed mycotic infection.
- Early diagnosis with Karius test led to timely and effective treatment.

## Abstract

We report the case of a 35-year-old female with advanced HIV diagnosed with a mixed mycotic infection. Diagnosis was assisted by Karius test. She was admitted with postpartum psychosis and developed fever and acute hypoxic respiratory failure initially thought to be from a bacterial hospital-acquired pneumonia. Due to lack of sufficient improvement on appropriate antibiotics, a broad infectious workup was sent. A Karius test was performed early during the workup. It returned positive for Pneumocystis jirovecii, Coccidioides posadasii, and Histoplasma capsulatum. Eventually a standard work up returned with a positive bronchoalveolar lavage (BAL) Pneumocystis jirovecii pneumonia (PJP) test by direct fluorescent antibody (DFA), positive Histoplasma urine antigen, and positive serum coccidioidal titer of 1:16, corroborating the diagnosis of mixed mycotic infection. She was treated with a 21-day course of trimethoprim-sulfamethoxazole followed by primaquine and clindamycin for PJP. She clinically improved with over 3 weeks of IV amphotericin B to cover for histoplasmosis and coccidioidomycosis, which was later de-escalated to oral itraconazole. She was instructed to follow up in clinic where bictegravir/emtricitabine/tenofovir alafenamide was initiated. This case highlights the utility of building a broad differential diagnosis as mixed mycotic infections can coexist in an immunocompromised host, and of utilizing a Karius test early in the course of illness in an immunocompromised patient to expedite a diagnosis. This case also demonstrates the need to recognize the changing geographic distribution of fungal infections.